Growing Market Applications, Centerline Biomedical Granted FDA 510(k) Clearance for IOPS® with New, Expanded Indication for Use
CLEVELAND–(BUSINESS WIRE)–Centerline Biomedical, Inc. (“Centerline”), an innovative leader in cardiovascular navigation and visualization systems, announced that the company has received US Food and Drug Administration (FDA) 510(k) clearance of expanded indications for its Intra-Operative Positioning System (IOPS). This news is complemented by the recent 510(k) clearance of the IOPS Fiducial Tracking Pad, a second-generation lower profile device useful in broader applications of the IOPS platform.
